Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications

BACKGROUND: Healthcare access has changed drastically during the COVID-19 pandemic. Elective medical procedures, including routine office visits, were restricted raising concerns regarding opioid and benzodiazepine provider and prescription availability. OBJECTIVE: To examine how the cancelation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Downs, Callie G., Varisco, Tyler J., Bapat, Shweta S., Shen, Chan, Thornton, J. Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738763/
https://www.ncbi.nlm.nih.gov/pubmed/33317769
http://dx.doi.org/10.1016/j.sapharm.2020.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738763/
https://www.ncbi.nlm.nih.gov/pubmed/33317769
http://dx.doi.org/10.1016/j.sapharm.2020.06.003

Ejemplares similares